These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9587193)

  • 1. Antibacterial and anti-inflammatory agents that target endotoxin.
    Wyckoff TJ; Raetz CR; Jackman JE
    Trends Microbiol; 1998 Apr; 6(4):154-9. PubMed ID: 9587193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis.
    Morrison DC; Bucklin SE
    Scand J Infect Dis Suppl; 1996; 101():3-8. PubMed ID: 9060044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics, cytokines, and endotoxin: a complex and evolving relationship in gram-negative sepsis.
    Horn DL; Opal SM; Lomastro E
    Scand J Infect Dis Suppl; 1996; 101():9-13. PubMed ID: 9060045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid a biosynthesis of multidrug-resistant pathogens - a novel drug target.
    Lee CR; Lee JH; Jeong BC; Lee SH
    Curr Pharm Des; 2013; 19(36):6534-50. PubMed ID: 23829374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lipid A biosynthesis as the primary mechanism of CHIR-090 antibiotic activity in Escherichia coli.
    Barb AW; McClerren AL; Snehelatha K; Reynolds CM; Zhou P; Raetz CR
    Biochemistry; 2007 Mar; 46(12):3793-802. PubMed ID: 17335290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic induced endotoxin release and clinical sepsis: a review.
    Holzheimer RG
    J Chemother; 2001 Nov; 13 Spec No 1(1):159-72. PubMed ID: 11936361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marine compounds with therapeutic potential in gram-negative sepsis.
    Solov'eva T; Davydova V; Krasikova I; Yermak I
    Mar Drugs; 2013 Jun; 11(6):2216-29. PubMed ID: 23783404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on endotoxin neutralization strategies in Gram-negative bacterial infections.
    Brandenburg K; Schromm AB; Weindl G; Heinbockel L; Correa W; Mauss K; Martinez de Tejada G; Garidel P
    Expert Rev Anti Infect Ther; 2021 Apr; 19(4):495-517. PubMed ID: 33210958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new class of UDP-3-O-(R-3-hydroxymyristol)-N-acetylglucosamine deacetylase (LpxC) inhibitors for the treatment of Gram-negative infections: PCT application WO 2008027466.
    Cuny GD
    Expert Opin Ther Pat; 2009 Jun; 19(6):893-9. PubMed ID: 19473108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fundamentals of endotoxin structure and function.
    Bishop RE
    Contrib Microbiol; 2005; 12():1-27. PubMed ID: 15496774
    [No Abstract]   [Full Text] [Related]  

  • 11. De novo designed lipopolysaccharide binding peptides: structure based development of antiendotoxic and antimicrobial drugs.
    Bhattacharjya S
    Curr Med Chem; 2010; 17(27):3080-93. PubMed ID: 20629624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides with dual mode of action: Killing bacteria and preventing endotoxin-induced sepsis.
    Brandenburg K; Heinbockel L; Correa W; Lohner K
    Biochim Biophys Acta; 2016 May; 1858(5):971-9. PubMed ID: 26801369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic-induced endotoxin release from bacteria and its clinical significance.
    Kirikae T; Nakano M; Morrison DC
    Microbiol Immunol; 1997; 41(4):285-94. PubMed ID: 9159401
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular mechanisms of membrane targeting antibiotics.
    Epand RM; Walker C; Epand RF; Magarvey NA
    Biochim Biophys Acta; 2016 May; 1858(5):980-7. PubMed ID: 26514603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide as a target for the development of novel therapeutics in gram-negative bacteria.
    Yethon JA; Whitfield C
    Curr Drug Targets Infect Disord; 2001 Aug; 1(2):91-106. PubMed ID: 12455407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis.
    Morrison DC
    Prog Clin Biol Res; 1998; 397():199-207. PubMed ID: 9575560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of antibiotic-induced endotoxin release in septic shock.
    Lepper PM; Held TK; Schneider EM; Bölke E; Gerlach H; Trautmann M
    Intensive Care Med; 2002 Jul; 28(7):824-33. PubMed ID: 12122518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antibacterial agents for treating infections caused by multi-drug resistant Gram-negative bacteria.
    O'Neill AJ
    Expert Opin Investig Drugs; 2008 Mar; 17(3):297-302. PubMed ID: 18321229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antibiotics on gram-negative sepsis in the rat. Lack of endotoxin burst.
    Almdahl SM; Osterud B
    Acta Chir Scand; 1987 Apr; 153(4):283-6. PubMed ID: 3307255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-based treatment of sepsis.
    Brandenburg K; Andrä J; Garidel P; Gutsmann T
    Appl Microbiol Biotechnol; 2011 May; 90(3):799-808. PubMed ID: 21369803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.